"Kudos! I've seen the mobile-formatted website for Fertility & Sterility, and the design is beautiful. We're impressed with the greater readability of the forthcoming website version from mobile devices. So many physicians keep up to date from their mobile phone - this is needed to complement our journal iTunes app," added Dr. Niederberger.
"The priorities for this investment reflect what Elsevier has heard from its journal subscribers as well as what societies have expressed as their top digital platform priorities," said Glen Campbell, Elsevier's Executive Vice President of Society Business Development. "We look forward to customizing these services carefully with each of our society partners. We will extend this new platform's capability to our society journals in the Physical and Social Sciences as we expand our society business in those domains."
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL. Media contact Christopher Capot Director, Corporate Relations Elsevier +1-212-633-3164 firstname.lastname@example.org SOURCE Elsevier